Stay updated on Lanabecestat in Early Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Lanabecestat in Early Alzheimer's Disease Clinical Trial page.

Latest updates to the Lanabecestat in Early Alzheimer's Disease Clinical Trial page
- CheckyesterdayChange DetectedThe page now reports an updated ClinicalTrials.gov site software revision in its footer, moving from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now shows revision v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check51 days agoChange DetectedSite revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check73 days agoChange DetectedFooter shows a minor revision update from v3.4.1 to v3.4.2 with no changes to study content, navigation, or data presentation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0. This is a minor version update with no impact on study details or user actions.SummaryDifference0.0%

- Check94 days agoChange DetectedThese changes are minor editorial/UI updates: an additional glossary display option, capitalization tweaks in the QC criteria label, the inclusion of No FEAR Act Data, and a new revision tag (v3.4.0), none of which modify core study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Lanabecestat in Early Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanabecestat in Early Alzheimer's Disease Clinical Trial page.